Evaluation of Prolonged Versus Continuous Infusions of Piperacillin/Tazobactam During Shortages of Small Volume Parenteral Solutions

E Tschumper, K Dupuis, K McCrory… - Journal of Pharmacy …, 2021 - journals.sagepub.com
Background: In 2017, a national drug shortage of small volume solutions significantly
affected the preparation of intravenous antibiotics. In response, a continuous infusion …

In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products

CA Rodriguez, M Agudelo, AF Zuluaga… - International journal of …, 2017 - Elsevier
Recent studies have shown that the pharmacodynamic (PD) index driving the efficacy of β-
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …

A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring

TKL Kiang, UO Häfeli, MHH Ensom - Clinical pharmacokinetics, 2014 - Springer
The objective of the current review was to provide an updated and comprehensive summary
on pharmacokinetic data describing the distribution of antimicrobials into interstitial fluid …

Development and implementation of a piperacillin-tazobactam extended infusion guideline

LS Heinrich, S Tokumaru, NM Clark… - Journal of …, 2011 - journals.sagepub.com
Administration of β-lactam antibiotics by extended infusion optimizes the pharmacodynamic
properties and bactericidal activity of these agents resulting in a potential improvement in …

[HTML][HTML] We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?

MO Cotta, JA Roberts, J Lipman - Critical Care, 2016 - Springer
Conclusions Zander and colleagues have provided new information on target attainment of
PIP concentrations in a heterogeneous group of critically ill patients. Among patients without …

[HTML][HTML] Population pharmacokinetics of piperacillin in non-critically ill patients with bacteremia caused by enterobacteriaceae

V Merino-Bohórquez, F Docobo-Pérez… - Antibiotics, 2021 - mdpi.com
This study analyzes the pharmacokinetic variability of piperacillin in non-critically ill patients
with Enterobacteriaceae bloodstream infections (EBSI) and explores predicted clinical …

Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients

SAM Dhaese, JA Roberts, M Carlier… - International journal of …, 2018 - Elsevier
Dosing recommendations for continuous infusion of piperacillin, a broad-spectrum beta-
lactam antibiotic, are mainly guided by outputs from population pharmacokinetic models …

Pharmacokinetics of an extended 4‐hour infusion of piperacillin‐tazobactam in critically ill patients undergoing continuous renal replacement therapy

DK Awissi, A Beauchamp, E Hébert… - … : The Journal of …, 2015 - Wiley Online Library
Study Objective To evaluate the pharmacokinetic and pharmacodynamic profiles of
piperacillin‐tazobactam administered as a 4‐hour infusion in critically ill patients undergoing …

Pharmacoeconomics of continuous versus intermittent infusion of piperacillin–tazobactam for the treatment of complicated intraabdominal infection

CA DeRyke, JL Kuti, D Mansfield… - American journal of …, 2006 - academic.oup.com
Piperacillin sodium–tazobactam sodium, a β-lactam antimicrobial, is extensively used
because of its broad-spectrum activity against many enteric gram-negative pathogens …

Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini‐review and population …

DJ Selig, JP DeLuca, KK Chung… - Journal of Clinical …, 2022 - Wiley Online Library
What is known and objective Timely and appropriate dosing of antibiotics is essential for the
treatment of bacterial sepsis. Critically ill patients treated with continuous kidney …